As of March 23, 2026, Rigel Pharmaceuticals's top three insider holders are Raul R Rodriguez (Ceo, President, 282.02K shares), Brian L. Kotzin (Director, 100.00K shares), Dean L Schorno (Evp Chief Financial Officer, 76.34K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Raul R Rodriguez | Ceo, President | 282,017 | 0 | 19 Feb, 2026 |
| Brian L. Kotzin | 100,000 | 0 | 29 May, 2024 | |
| Dean L Schorno | Evp Chief Financial Officer | 76,337 | 0 | 19 Feb, 2026 |
| Gary A Lyons | 75,000 | 0 | 12 Jul, 2023 | |
| Wolfgang Dummer | Evp Cmo | 72,459 | 0 | 06 Feb, 2023 |
| David A Santos | Evp, Chief Commercial Officer | 62,870 | 0 | 19 Feb, 2026 |
| Dolly Vance | Evp Corp. Affairs, G.C., Sect. | 60,260 | 0 | 26 Jan, 2022 |
| Raymond J. Furey | Evp, Gc, Cco Corp Sec | 51,813 | 0 | 19 Feb, 2026 |
| Bradford S Goodwin | 35,000 | 0 | 21 May, 2021 | |
| Lisa Rojkjaer | Evp, Chief Medical Officer | 34,853 | 0 | 19 Feb, 2026 |
| Keith Katkin | 25,000 | 0 | 21 May, 2021 | |
| Walter H Moos | 12,722 | 0 | 24 Feb, 2026 | |
| Anthony Gregg Lapointe | 12,500 | 0 | 28 May, 2025 | |
| Jane Wasman | 12,500 | 0 | 28 May, 2025 | |
| Alison L. Hannah | 10,625 | 0 | 28 May, 2025 | |
| Kamil Ali-Jackson | 9,375 | 0 | 28 May, 2025 | |
| Mark W Frohlich | 1,250 | 0 | 28 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Feb, 2026 | Walter H Moos | Common Stock | A | 4,000 | $24.00 | 16,722 | D | M |
| 20 Feb, 2026 | Walter H Moos | Common Stock | D | 4,000 | $36.36 | 12,722 | D | S |
| 20 Feb, 2026 | Walter H Moos | Stock Option (right to buy) | D | 4,000 | $0.00 | 0 | D | M |
| 17 Feb, 2026 | Raymond J. Furey | Common Stock | A | 19,497 | $0.00 | 51,813 | D | A |
| 17 Feb, 2026 | Lisa Rojkjaer | Common Stock | A | 18,894 | $0.00 | 34,853 | D | A |
| 17 Feb, 2026 | David A Santos | Common Stock | A | 19,430 | $0.00 | 62,870 | D | A |
| 17 Feb, 2026 | Dean L Schorno | Common Stock | A | 20,636 | $0.00 | 76,337 | D | A |
| 17 Feb, 2026 | Raul R Rodriguez | Common Stock | A | 53,915 | $0.00 | 282,017 | D | A |
| 10 Feb, 2026 | David A Santos | Common Stock | D | 3,546 | $34.62 | 43,440 | D | F |
| 10 Feb, 2026 | Raul R Rodriguez | Common Stock | D | 7,607 | $34.62 | 228,102 | D | F |
| 10 Feb, 2026 | Lisa Rojkjaer | Common Stock | D | 3,758 | $34.62 | 15,959 | D | F |
| 10 Feb, 2026 | Raymond J. Furey | Common Stock | D | 3,546 | $34.62 | 32,316 | D | F |
| 10 Feb, 2026 | Dean L Schorno | Common Stock | D | 3,546 | $34.62 | 55,701 | D | F |
| 26 Jan, 2026 | Raul R Rodriguez | Common Stock | A | 40,000 | $27.40 | 280,454 | D | M |
| 02 Feb, 2026 | Raymond J. Furey | Common Stock | D | 3,968 | $36.01 | 35,862 | D | F |
| 02 Feb, 2026 | David A Santos | Common Stock | D | 5,718 | $36.01 | 46,986 | D | F |
| 02 Feb, 2026 | Dean L Schorno | Common Stock | D | 5,488 | $36.01 | 59,247 | D | F |
| 26 Jan, 2026 | Raul R Rodriguez | Common Stock | D | 35,211 | $37.00 | 245,243 | D | F |
| 26 Jan, 2026 | Raul R Rodriguez | Common Stock | A | 40,000 | $27.40 | 285,243 | D | M |
| 26 Jan, 2026 | Raul R Rodriguez | Common Stock | D | 35,424 | $37.00 | 249,819 | D | F |